Kamiyama Toshiya, Hige Shuhei, Sakuhara Yusuke, Chuma Makoto, Shimamura Tsuyoshi
Department of General Surgery, Hokkaido University Graduate School of Medicine, Sapporo 060-8648, Japan.
Hokkaido Igaku Zasshi. 2011 May;86(3):127-30.
In this symposium, we explained etiology, prevention and treatment for hepatocellular carcinoma (HCC). It has been revealed that the carcinogenesis in hepatocellular carcinoma is almost caused by the infection of hepatitis virus B and/or C. Therefore, the carcinogenesis in hepatocellular carcinoma is able to be prevented. Even if the carcinogenesis in hepatocellular carcinoma occurs, the diagnosis and treatment in the worldwide level; radiofrequency ablation (RFA), transcatheter arterial chemoembolization (TACE), hepatectomy, and liver transplantation will be offered to patients with HCC in Japan. We hope that this symposium would help the attendance to understand the prevention and treatment for HCC.
在本次研讨会上，我们阐述了肝细胞癌（HCC）的病因、预防和治疗。已发现肝细胞癌的致癌作用几乎是由乙型和/或丙型肝炎病毒感染引起的。因此，肝细胞癌的致癌作用是可以预防的。即使发生了肝细胞癌的致癌作用，在全球范围内针对肝细胞癌患者的诊断和治疗手段，如射频消融（RFA）、经动脉化疗栓塞（TACE）、肝切除术和肝移植，在日本都可供使用。我们希望本次研讨会能帮助与会者了解肝细胞癌的预防和治疗。
